Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).

One of the metabolic fates of 3-deoxyglucosone, a product of protein deglycation and a potent glycating agent, is to be oxidized to 2-keto-3-deoxygluconate, but the enzyme that catalyzes this reaction is presently unknown. Starting from human erythrocytes, which are known to convert 3-deoxyglucosone to 2-keto-3-deoxygluconate, we have purified to near homogeneity a NAD-dependent dehydrogenase that catalyzes this last reaction at neutral pH. Sequencing of a 55 kDa band co-eluting with the enzymatic activity in the last step indicated that it corresponded to aldehyde dehydrogenase 1A1 (ALDH1A1), an enzyme known to catalyze the oxidation of retinaldehyde to retinoic acid. Overexpression of human ALDH1A1 in HEK cells led to a more than 20-fold increase in 3-deoxyglucosone dehydrogenase activity. In mouse tissues 3-deoxyglucosone dehydrogenase activity was highest in liver, intermediate in lung and testis, and negligible or undetectable in other tissues, in agreement with the tissue distribution of ALDH1A1 mRNA. 3-deoxyglucosone dehydrogenase activity was undetectable in tissues from ALDH1A1(-/-) mice. ALDH1A1 appears therefore to be the major if not the only enzyme responsible for the oxidation of 3-deoxyglucosone to 2-keto-3-deoxygluconate. The urinary excretion of 2-keto-3-deoxygluconate amounted to 16.7 micromol/g creatinine in humans, indicating that 3-deoxyglucosone may be quantitatively a more important substrate than retinaldehyde for ALDH1A1.

[1]  V. Vasiliou,et al.  Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. , 2000, Chemico-biological interactions.

[2]  A. Lamb,et al.  The structure of retinal dehydrogenase type II at 2.7 A resolution: implications for retinal specificity. , 1999, Biochemistry.

[3]  D. V. Vander Jagt,et al.  Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. , 2003, Chemico-biological interactions.

[4]  J. Baynes,et al.  The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.

[5]  D. Vertommen,et al.  Identification of a dehydrogenase acting on D-2-hydroxyglutarate. , 2004, The Biochemical journal.

[6]  J. Dunkerton,et al.  Purification of 2-oxoaldehyde dehydrogenase and its dependence on unusual amines. , 1975, The Biochemical journal.

[7]  Taniguchi Naoyuki,et al.  Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression , 1993 .

[8]  F. Collard,et al.  Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. , 2002, The Biochemical journal.

[9]  P. Chambon,et al.  A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Duester,et al.  Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid. , 1999, The Biochemical journal.

[11]  K. Sato,et al.  Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase. , 1993, Archives of biochemistry and biophysics.

[12]  V. Vasiliou,et al.  Role of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism , 2004, Drug metabolism reviews.

[13]  T. Niwa.  3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[14]  B. Szwergold,et al.  Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo. , 2001, Diabetes.

[15]  E. Schaftingen,et al.  Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. , 2000, Diabetes.

[16]  C. Monder.  Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate. , 1967, The Journal of biological chemistry.

[17]  H. Baker,et al.  Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. , 1998, Structure.

[18]  G. Duester,et al.  Kinetic analysis of mouse retinal dehydrogenase type-2 (RALDH2) for retinal substrates. , 2002, Biochimica et biophysica acta.

[19]  T. Flynn,et al.  Catalysis of reduction of carbohydrate 2-oxoaldehydes (osones) by mammalian aldose reductase and aldehyde reductase. , 1995, Biochimica et biophysica acta.

[20]  S. Lipton,et al.  Targeted Disruption of Aldh1a1 (Raldh1) Provides Evidence for a Complex Mechanism of Retinoic Acid Synthesis in the Developing Retina , 2003, Molecular and Cellular Biology.

[21]  M. Takahashi,et al.  Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. , 1993, Gene.

[22]  E. Fujii,et al.  The presence of 2-keto-3-deoxygluconic acid and oxoaldehyde dehydrogenase activity in human erythrocytes. , 1995, Biochemical and biophysical research communications.

[23]  G. Duester,et al.  Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning , 2006, Development.

[24]  P. Chambon,et al.  Embryonic retinoic acid synthesis is essential for early mouse post-implantation development , 1999, Nature Genetics.